Sajulga, Emma .
HRN: 22-98-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2025
CEFUROXIME 1.5GM (VIAL)
02/25/2025
02/26/2025
IV
1.5g
PTOR
PTOR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes